
In News
- Recently, the Union Minister of Science and Technology announced the scientific completion of Cervavac which is India’s first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine for the prevention of cervical cancer.
|
Data/ Facts
|
About Cervavac
- Manufacturer:
- Cervavac is developed by the Pune-based Serum Institute of India in coordination with the Government of India’s Department of Biotechnology (DBT).
- Virus:
- Almost all cervical cancer cases are linked to certain strains of human papillomavirus (HPV), a common virus that is transmitted through sexual contact.
- Lifecycle:
- While the body’s immune system usually gets rid of the HPV infection naturally within two years, in a small percentage of people the virus can linger over time and turn some normal cells into abnormal cells and then cancer.
- Prevention
- Screening and vaccination are two powerful tools that are available for preventing cervical cancer.
- There is little awareness among women about the prevention of this cancer and less than 10% of Indian women get screened.
- All women aged 30-49 must get screened for cervical cancer even if they have no symptoms and get their adolescent daughters vaccinated with the HPV vaccine.
- How common is cervical cancer in India?
- India accounts for about a fifth of the global burden of cervical cancer, with 1.23 lakh cases and around 67,000 deaths per year.
- It kills one woman every 8 minutes in the country.
- How effective is the new vaccine?
- HPV vaccines are given in two doses and data has shown that the antibodies that develop after both are administered can last up to six or seven years.
- Booster shots may not be required for the cervical cancer vaccine.
- It is likely to be significantly cheaper, slated to cost approximately Rs 200 to 400.
- Challenges
- The biggest task will be in allocating adequate resources and manpower for vaccinating the massive demographic of adolescent girls aged between 9 and 15.
- There is a huge need for stepping up awareness about the disease and the vaccine in the community.
- Screening is very low in the community and that is a concern.
Source: IE
Previous article
NCRB Data on Human Trafficking
Next article
INS Vikrant: First Indigenous Aircraft Carrier